Seattle, WA, United States of America

Rimas J Orentas

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 119(Granted Patents)


Location History:

  • Chevy Chase, MD (US) (2017 - 2022)
  • Washington, DC (US) (2018 - 2024)
  • Seattle, WA (US) (2019 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: The Innovations of Rimas J Orentas: Pioneering Cancer Treatment in Seattle

Introduction:

Rimas J Orentas is a prolific inventor based in Seattle, Washington. With a staggering 34 patents to his name, Orentas has been at the forefront of developing cutting-edge immunotherapies for cancer treatment.

Latest Patents:

Two of his latest patents showcase his commitment to advancing cancer treatment. The first patent involves the development of compositions and methods for treating cancer with anti-mesothelin immunotherapy. This includes chimeric antigen receptors that target mesothelin, along with innovative methods for treating or preventing cancer in patients.

The second patent focuses on chimeric antigen receptors containing tumor necrosis factor receptor superfamily member transmembrane domains. This patent also includes methods for making chimeric antigen receptor T cells and treating cancer in a subject. Orentas' work in this area highlights his dedication to pushing the boundaries of cancer immunotherapy.

Career Highlights:

Throughout his career, Rimas J Orentas has made significant contributions to the field of biotechnology. He has worked with esteemed companies such as Lentigen Technology, Inc. and The United States of America, as Represented by the Secretary, Department of Health and Human Services. These collaborations have allowed Orentas to translate his innovative ideas into tangible products that have the potential to revolutionize cancer treatment.

Collaborations:

Orentas has had the privilege of working alongside talented individuals in the field of biotechnology. Some of his notable coworkers include Dina Schneider and Boro Dropulic. These collaborations have been instrumental in bringing Orentas' groundbreaking ideas to fruition and have paved the way for future innovations in cancer therapy.

Conclusion:

Rimas J Orentas stands as a beacon of innovation in the field of cancer treatment. His numerous patents and collaborations underscore his unwavering dedication to advancing immunotherapy for the benefit of cancer patients worldwide. Orentas' work serves as a testament to the power of innovation and collaboration in driving progress in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…